Pharmaceutical

Lantern Pharma and Oregon partner to develop cancer treatment

Lantern Pharma has entered into a partnership with Oregon for optimising the development of XCE853, through an AI-driven approach.

May 7, 2024 - 00:00
Lantern Pharma and Oregon partner to develop cancer treatment
Lantern Pharma has entered into a partnership with Oregon for optimising the development of XCE853, through an AI-driven approach.
Read the original article

Tags:

Previous Article

Cipla and Glenmark initiate recall of certain products in the US

Next Article

UK MHRA approves ViiV Healthcare’s cabotegravir formulations for HIV-1

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: ITC recommends partial import ban of Apple Watches in Masimo patent case

STAT+: ITC recommends partial import ban of Apple Watch...

Oct 28, 2023

STAT+: New NIH head says government has fallen behind pharma on clinical trials

STAT+: New NIH head says government has fallen behind p...

Nov 15, 2023

Sanofi’s frexalimab shows early potential in in Phase II multiple sclerosis trial

Sanofi’s frexalimab shows early potential in in Phase I...

Jun 1, 2023